Get started
Author

Maria Eveslage

Observed names: Eveslage, Maria, M Eveslage, M. Eveslage
Observed institutions: The University of Sydney, Carl von Ossietzky Universität Oldenburg, Memorial Sloan Kettering Cancer Center, University of Groningen, Johannes Gutenberg University Mainz, TU Dortmund University, University of Münster, University Hospital Regensburg, University Medical Center of the Johannes Gutenberg University Mainz, German Rheumatism Research Centre, Nanfang Hospital, University Hospital Münster, University Medical Center Hamburg-Eppendorf, Klinikum Oldenburg, Essen University Hospital, Osaka Hospital, Universitätsklinikum Würzburg, Stiftung Universitätsmedizin Essen, Southern Medical University, University of Duisburg-Essen, Medical University of Vienna, Srinakharinwirot University, Leipzig University
ORCID: 0000-0002-8802-1134
Observed ORCID: 0000-0002-8802-1134
OpenAlex ID: A5037414415
German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
2016 · Kambiz Rahbar, Hojjat Ahmadzadehfar, et al. · Journal of Nuclear Medicine · 832
PDF
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
2011 · A Strangfeld, M Eveslage, et al. · Annals of the Rheumatic Diseases · 368
PDF
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival
2017 · K. Rahbar, M. Boegemann, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 158
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
2019 · Luisa Klotz, Melanie Eschborn, et al. · Science Translational Medicine · 145
Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity
2018 · Marie Liebmann, Stephanie Hucke, et al. · Proceedings of the National Academy of Sciences · 120
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
2016 · Carsten Weishaupt, Anke Strölin, et al. · The Lancet Haematology · 96
History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis
2015 · Anika Hoffmann, Svenja Boekhoff, et al. · European Journal of Endocrinology · 93
Association of obesity with disease outcome in multiple sclerosis
2022 · Isabel Lutfullin, Maria Eveslage, et al. · Journal of Neurology Neurosurgery & Psychiatry · 91
PDF
Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma
2019 · Agnieszka Bogusz, Svenja Boekhoff, et al. · Endocrine Connections · 82
PDF
Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007
2017 · Kerstin Heinks, Svenja Boekhoff, et al. · Endocrine · 82
Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
2017 · Kambiz Rahbar, Martin Bögeman, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 76
Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity
2015 · Claudia Lanvers-Kaminsky, Jason A Sprowl, et al. · Pharmacogenomics · 76
Corneal Densitometry, Central Corneal Thickness, and Corneal Central-to-Peripheral Thickness Ratio in Patients With Fuchs Endothelial Dystrophy
2015 · Maged Alnawaiseh, Lars Zumhagen, et al. · Cornea · 72
Characteristics, risk factors and treatment reality in livedoid vasculopathy – a multicentre analysis
2019 · C. Weishaupt, A. Strölin, et al. · Journal of the European Academy of Dermatology and Venereology · 70
The Postoperative Quality of Life in Children and Adolescents with Craniopharyngioma
2019 · Maria Eveslage, Gabriele Calaminus, et al. · Deutsches Ärzteblatt international · 69
Oxytocin in survivors of childhood-onset craniopharyngioma
2016 · Anna M. M. Daubenbüchel, Anika Hoffmann, et al. · Endocrine · 69
Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)
2018 · Svenja Boekhoff, Agnieszka Bogusz, et al. · European Journal of Endocrinology · 66
Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial
2016 · Stephan Ehrhardt, Nan Guo, et al. · Open Forum Infectious Diseases · 66
PDF
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
2013 · Kornelius Kerl, David Ries, et al. · BMC Cancer · 64
PDF
Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS)
2021 · Malte Lenders, Peter Nordbeck, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 62
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis
2021 · Melanie Eschborn, Marc Pawlitzki, et al. · Neurology Neuroimmunology & Neuroinflammation · 54
PDF
Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation
2018 · Ines Ellermann, Andreas Bueckmann, et al. · Anesthesia & Analgesia · 54
PDF
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
2024 · Catharina C. Gross, Catharina C. Gross, et al. · Science Translational Medicine · 52
Accelerated (18 mW/cm2) Corneal Collagen Cross-Linking for Progressive Keratoconus
2015 · Maged Alnawaiseh, André Rosentreter, et al. · Cornea · 50
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
2015 · C Müller-Tidow, P Tschanter, et al. · Leukemia · 49
Works count: 155
Citation count: 4,139
H-index: 36
I10-index: 59
Year
Topic
Type